ORAI3 and prostate carcinoma: In particular, the expression level of Orai3 in prostate cancer biopsies is upregulated [256], which leads to a reduction in SOCE and enhanced Ca2+ influx mediated by arachidonic acid (AA)-activated ARC channels [256].